Reward Processing and Depressive Subtypes: Identifying Neural Biotypes
Launched by SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER · Oct 5, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding how the brain processes rewards and how this relates to different types of depression. Researchers want to learn more about why some people with depression have low motivation and find little pleasure in activities. They believe that the way the brain anticipates and reacts to rewards might be different for each person, and identifying these differences could help improve treatment options.
To participate in the study, you need to be between 18 and 70 years old and diagnosed with major depressive disorder (MDD) or be a comparison participant without depression. You'll have some in-person visits at a research lab in San Francisco, where you may undergo an MRI scan. Before the MRI, you'll need to ensure there’s no metal in your body and that you're comfortable in the scanner. Unfortunately, individuals with certain medical conditions, neurological issues, or who are pregnant cannot participate. This research is important as it aims to discover specific brain markers that could lead to better understanding and treatment of depression.
Gender
ALL
Eligibility criteria
- • Our studies require some in-person visits to our research lab, located at 42nd Ave and Clement St in San Francisco.
- • Because this study includes an MRI, part of the screening process will be to ensure you don't have any metal in your body, you do not have head or neck tattoos, and you are comfortable inside the MRI scanner.
- Inclusion Criteria:
- • 18-70 years with a diagnosis of major depressive disorder (MDD) for MDD group, or without for unaffected comparison (UC) group
- • Negative metal screen for MRI safety
- • Normal (or corrected to normal) vision
- Exclusion Criteria:
- • Past or present neurological problems (including seizures and head trauma resulting in neurological or cognitive symptoms)
- • Loss of consciousness (LOC) greater than 30 minutes or any LOC with neurologic symptoms
- • Major medical conditions (e.g., seizure disorders, treatment with anticonvulsant medication, endocrine disorders, significant cardiac pathology)
- • Substance dependence, within the past year, or failed urine toxicology on the day of neuroimaging sessions
- • Known claustrophobia
- • Current Pregnancy
- • IQ estimate \< 70
About San Francisco Veterans Affairs Medical Center
The San Francisco Veterans Affairs Medical Center (SFVAMC) is a leading institution dedicated to advancing healthcare for veterans through innovative clinical research and comprehensive medical services. As a part of the Department of Veterans Affairs, SFVAMC focuses on improving the health and well-being of veterans by conducting rigorous clinical trials that address a wide range of medical conditions. The center is committed to fostering collaboration among healthcare professionals, researchers, and the veteran community to translate scientific discoveries into effective treatments and improve patient outcomes. With a strong emphasis on evidence-based practices, SFVAMC plays a pivotal role in enhancing the quality of care for those who have served in the armed forces.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
Patients applied
Trial Officials
Susanna L Fryer, PhD
Principal Investigator
University of California, San Francisco
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported